DeutschNewstral
Article
The Jerusalem Post (JPost.com) on 2020-04-14 03:52
China approves 2 experimental COVID-19 vaccines to enter clinical trials
Related news
Coronavirus: Hong Kong approves clinical trials for 3 Chinese vaccines targeting OmicronSouth China Morning Post- PChina approves experimental coronavirus vaccine trialspendect.com
- China approves coronavirus vaccine for clinical trialsThe Jerusalem Post (JPost.com)
China approves two coronavirus vaccines for human trialsAl Jazeera
Cancer vaccines enter clinical trialsPhilly.com
COVID-19 vaccines now in phase 3 clinical trials — WHOvanguardngr.com
Japanese firms launch domestic clinical trials for COVID-19 vaccinesThe Japan Times- Coronavirus: Gilead says experimental drug remdesivir helped Covid-19 patients in clinical trialsSouth China Morning Post
- NCOVID-19 vaccines near end of clinical trials, but distribution still a way offnomenugget.net
- Coronavirus: exempt emergency vaccines from late-stage clinical trials, Chinese health official urges WHOSouth China Morning Post
- Taiwan defends rush to buy 20 million doses of local vaccines still in clinical trialsSouth China Morning Post
Drugmakers Have Set Speed Records in Devising Coronavirus Vaccines and Beginning Clinical Trialsclevescene.com- WChina approves new drug to treat Alzheimer’s; clinical trials planned for 2020 in USwraltechwire.com
- China's Sinopharm offers experimental COVID-19 vaccines to studentsThe Jerusalem Post (JPost.com)
In clinical and real world trials, China’s Sinovac underperformsThe Economist- Covid-19: China’s Sinopharm mRNA vaccine approved for clinical trialsSouth China Morning Post
- SChina approves CSPC, Cansino mRNA vaccines for clinical trial, boosting country’s arsenal against raging Omicron outbreakscmp.com
- China says it has five coronavirus vaccines in human trialsThe Japan Times
- HChina Sinopharm’s Potential COVID-19 Vaccine Triggers Antibodies in Clinical Trialshamodia.com
Beijing mandates COVID vaccines to enter some public spacesSeattle Times